<!doctype html>
<html class="no-js" lang="en" dir="ltr">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="x-ua-compatible" content="ie=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Multiple Sclerosis Genetics Research Lab</title>
    <link rel="stylesheet" href="foundation/css/foundation.css">
    <link rel="stylesheet" href="foundation/css/app.css">
    <link href='https://fonts.googleapis.com/css?family=Raleway:400,700' rel='stylesheet' type='text/css'>
    <link rel="stylesheet" href="font-awesome/css/font-awesome.min.css">
    <link rel="stylesheet" type="text/css" href="css/custom.css">
  </head>
  <body>


    <div class="off-canvas-wrapper">
      <div class="off-canvas-wrapper-inner" data-off-canvas-wrapper>

        <!-- off-canvas title bar for 'small' screen -->
        <div class="title-bar" data-responsive-toggle="widemenu" data-hide-for="medium">
          <div class="title-bar-left">
            <button class="menu-icon" type="button" data-open="offCanvasLeft"></button>
          </div>
        </div>

        <!-- off-canvas left menu -->
        <div class="off-canvas position-left" id="offCanvasLeft" data-off-canvas>
          <ul class="vertical dropdown menu" data-dropdown-menu>
                <li><a href="index.html">Home</a></li>
                <li><a href="about.html">About Us</a></li>
                <li>
                  <a href="faculty.html">People</a>
                  <ul class="menu vertical no-border">
                  <li><a href="faculty.html">Faculty</a></li>
                  <li><a href="fellows.html">Fellows</a></li>
                  <li><a href="staff.html">Staff</a></li>
                  </ul>
                </li>
                <li><a href="research.html">Research</a></li>
                <li><a href="clinics.html">Clinics</a></li>
                <li><a href="jobs.html">Jobs/Opportunities</a></li>
          </ul>
        </div>

        <div id="widemenu" class="top-bar">
          <div class="top-bar-right">
            <ul class="dropdown menu" data-dropdown-menu>
                <li><a href="index.html">Home</a></li>
                <li><a href="about.html">About Us</a></li>
                <li>
                  <a href="faculty.html">People</a>
                  <ul class="menu vertical no-border">
                  <li><a href="faculty.html">Faculty</a></li>
                  <li><a href="fellows.html">Fellows</a></li>
                  <li><a href="staff.html">Staff</a></li>
                  </ul>
                </li>
                <li><a href="research.html">Research</a></li>
                <li><a href="clinics.html">Clinics</a></li>
                <li><a href="jobs.html">Jobs/Opportunities</a></li>
            </ul>
          </div>
        </div>

        <div class="off-canvas-content" data-off-canvas-content>
          <div class="row column">




    <div class="callout large no-border small-padding">
      <div class="row column text-center ">
        <h1>Fellows</h1>
        <hr class='shorter-width black-border'>
      </div>
    </div>

    <div class='row'>
	  	<div class='small-12 medium-9 columns medium-centered'>
    		<h3 class='header'><strong>Noriko Isobe, M.D., Ph.D.</strong></h3>
    		<div><small>E-mail: <a href="mailto:Noriko.Isobe@ucsf.edu">Noriko.Isobe@ucsf.edu</a></small></div>
    		<br>
  			<img src="images/noriko.jpg" class='margin-image' align="right">
    		<p class='small-font'>Multiple sclerosis (MS) is relatively rare in Japan but there are many patients suffered from various neurological symptoms as same as in other countries. I am quite interested in how much genetic background contributes to MS susceptibility and efficacy of disease modifying therapies. Besides, I and colleagues are working for the association of individual genetic susceptibility or burden and clinical phenotypes.</p>  
        <h4>Education and Training</h4>
        <ul class='small-font circle-list-style'>
          <li>1997-2003 M.D., School of Medicine, Kyushu University, Japan</li>
          <li>2003-2004 Resident Kyushu University Hospital</li>
          <li>2004-2007 Neurological Resident Department of Neurology, Kyushu University Hospital/Saiseikai Fukuoka General Hospital</li>
          <li>2007-2010 Ph.D., Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University</li>
        </ul>    
        <ul class="accordion" data-accordion data-accordion data-allow-all-closed="true">
          <li class="accordion-item" data-accordion-item>
            <a href="#" class="accordion-title">Awards and Honors</a>
            <div class="accordion-content" data-tab-content>
              <ul class='small-font circle-list-style'>
                <li>2009 Travel grant for 26th Congress of  European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)</li>
                <li>2010 Travel grant for 27th Congress of ECTRIMS in Göteborg, Sweden</li>
                <li>2010 Grant for Research on Intractable diseases, The Association for Preventive Medicine of Japan</li>
                <li>2011 Post-doctoral Fellowship, The Uehara Memorial Foundation</li>
                <li>2011 Young Investigator Award, the 4th Congress of the Pan-AsianCommittee for Treatment and Research in Multiple Sclerosis (PACTRIMS)</li>
                <li>2011 Young Neuroimmunologist Award, the 23rd Annual Meeting of the Japanese Society for Neuroimmunology</li>
                <li>2012-2014 Postdoctoral Fellowship for Research Abroad, Japan Society for the Promotion of Science (JSPS)</li>
                <li>2014-present Research Fellowship for Young Scientists (PD), JSPS</li>
              </ul>
            </div>
          </li>
          <li class="accordion-item" data-accordion-item>
            <a href="#" class="accordion-title">Recent Publications</a>
            <div class="accordion-content" data-tab-content>
              <ul class='small-font circle-list-style'>
                <li>Isobe N, Madireddy L, Khankhanian P, Matsushita T, Caillier SJ, More JM, Gourraud PA, McCauley JL, Beecham A, International Multiple Sclerosis Genetics Consortium, Piccio L, Herbert J, Khan O, Cohen J, Stone L, Santaniello A, Cree BAC, Onengut-Gumuscu S, Rich SS, Hauser SL, Sawcer S, Oksenberg JR. An ImmunoChip study of multiple sclerosis risk in African Americans. Brain 2015 (in press)</li>
                <li>Nickles D, Madireddy L, Patel N, Isobe N, Miller BL, Baranzini SE, Kramer JH, Oksenberg JR. Whole genome sequences of 2 octogenarians with sustained cognitive abilities. Neurobiol Aging 2014 (in press).</li>
                <li>Isobe N, Oksenberg JR . Genetic studies of multiple sclerosis and neuromyelitis optica: current status in European, African American, and Asian populations . Clin Exp Neuroimmunol 2014, 5:61-8.</li>
                <li>Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler 2014, 20:660-8.</li>
                <li>Isobe N, Damotte V, Lo Re V, Ban M, Pappas D, Guillot-Noel L, Rebeix I, Compston A, Mack T, Cozen W, Fontaine B, Hauser SL, Oksenberg JR, Sawcer S, Gourraud PA. Genetic burden in multiple sclerosis families. Genes Immun 2013, 14:434-40.</li>
                <li>Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, Hauser SL, Oksenberg JR. Genetic risk variants in African Americans with multiple sclerosis. Neurology 2013, 81:219-27.</li>
                <li>McElroy JP, Isobe N, Gourraud PA, Caillier SJ, Matsushita T, Kohriyama T, Miyamoto K, Nakatsuji Y, Miki T, Hauser SL, Oksenberg JR, Kira J. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes Immun 2011, 12:523-30.</li>
                <li>Fang L,* Isobe N,* Yoshimura S, Yonekawa T, Matsushita T, Masaki K, Doi H, Ochi K, Miyamoto K, Kawano Y, Kira J for the South Japan Multiple Sclerosis Genetics Consortium. Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians. Neurology 2011, 76:2125-7. (*contributed equally)</li>
                <li>Isobe N, Kira J, Kawamura N, Ishizu T, Arimura K, Kawano Y. Neural damage associated with atopic diathesis: a nationwide survey in Japan. Neurology 2009, 73:790-7.</li>
              </ul>
            </div>
          </li>          
          <!-- ... -->
        </ul>              
    	</div>
    </div>

    <br>

    <div class='row'>
	  	<div class='small-12 medium-9 columns medium-centered'>
    		<h3 class='header '><strong>Alessandro Didonna, Ph.D.</strong></h3>
    		<div><small>E-mail: <a href="mailto:alessandro.didonna@ucsf.edu">alessandro.didonna@ucsf.edu</a></small></div>
    		<br>
    		<img src="images/alessandro.jpg" class='margin-image' align="right">
        <p class='small-font'>Multiple sclerosis (MS) is relatively rare in Japan but there are many patients suffered from various neurological symptoms as same as in other countries. I am quite interested in how much genetic background contributes to MS susceptibility and efficacy of disease modifying therapies. Besides, I and colleagues are working for the association of individual genetic susceptibility or burden and clinical phenotypes.</p>          
        <h4>Education and Training</h4>
        <ul class='small-font circle-list-style'>
          <li>2004-2006 M.S, Molecular Biology, University of Bari, Italy</li>
          <li>2006-2010 Ph.D., Prion Diseases, International School for Advanced Studies, Italy</li>
          <li>2009-Present Postdoctoral Fellow, Department of Neurology, University of California, San Francisco, CA</li>
          <li>2011-2013 Postdoctoral Fellow, Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL</li>
        </ul>   
        <ul class="accordion" data-accordion data-accordion data-allow-all-closed="true">
          <li class="accordion-item" data-accordion-item>
            <a href="#" class="accordion-title">Recent Publications</a>
            <div class="accordion-content" data-tab-content>
              <ul class='small-font circle-list-style'>
                <li>A Venkatraman, YS Hu, A Didonna, M Cvetanovic, A Krbanjevic, P Bilesimo,P Opal. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1. Hum Mol Genet 2014 Mar 6.</li>
                <li>A Didonna. Prion protein and its role in signal transduction. Cellular and Molecular Biology Letters 2013 Jun;18(2):209-30.</li>
                <li>S Mahammad, P Murthy, A Didonna, B Grin, E Israeli, R Perrot, P Bomont, J P Julien, E Kuczmarski, P Opal and R D Goldman. Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. Journal of clinical investigation 2013 May 1;123(5):1964-75</li>
                <li>A Didonna, J Sussman, F Benetti, G Legname. The role of Bax and caspase 3 in Doppel-induced apoptosis of cerebellar granule cells. Prion 2012 Jul 1;6(3).</li>
                <li>A Didonna, L Vaccari, A Bek, G Legname. FTIR Microspectroscopy: a multiple-screening platform for investigating single-cell biochemical perturbations upon prion infection. ACS Chemical Neuroscience 2011 Mar 16;2(3):160-74.</li>
                <li>A Didonna and G Legname. Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells. Molecular Neurodegeneration 2010 Aug 9;5:29.</li>
              </ul>
            </div>
          </li>          
        </ul>                                    
    	</div>
    </div>

    <br>

    <div class='row'>
      <div class='small-12 medium-9 columns medium-centered'>
        <h3 class='header '><strong>Ester Cantó Puig, Ph.D.</strong></h3>
        <div><small>E-mail: <a href="mailto:Ester.CantoPuig@ucsf.edu">Ester.CantoPuig@ucsf.edu</a></small></div>
        <br>
        <img src="images/ester.jpg" class='margin-image' align="right">
        <p class='small-font'>Multiple sclerosis (MS) is relatively rare in Japan but there are many patients suffered from various neurological symptoms as same as in other countries. I am quite interested in how much genetic background contributes to MS susceptibility and efficacy of disease modifying therapies. Besides, I and colleagues are working for the association of individual genetic susceptibility or burden and clinical phenotypes.</p>          
        <h4>Education and Training</h4>
        <ul class='small-font circle-list-style'>
          <li>2003-2008 BS, Pharmacy, Universitat de Barcelona, Spain</li>
          <li>2008-2009 Master’s degree in immunology; Universitat Autònoma de Barcelona – Universitat de Barcelona, Spain</li>
          <li>2009-2015 PhD, Multiple Sclerosis, Universitat Autònoma de Barcelona, Spain</li>
        </ul>   
        <ul class="accordion" data-accordion data-accordion data-allow-all-closed="true">
          <li class="accordion-item" data-accordion-item>
            <a href="#" class="accordion-title">Recent Publications</a>
            <div class="accordion-content" data-tab-content>
              <ul class='small-font circle-list-style'>
                <li>Cantó E, Tintoré M, Villar LM, Borrás E, Álvarez-Cermeño JC, Chiva C, Sabidó E, Rovira A,
                Montalban X, Comabella M. Validation of biomarkers associated with the conversion fromclinically isolated syndrome to multiple sclerosis. J Neuroinflammation. 2014 Nov 13;11:181.</li>
                <li>Fissolo N, Cantó E, Vidal-Jordana A, Castilló J, Montalban X, Comabella M. Levels of soluble 
                TNF-RII are increased in serum of patients with primary progressive multiple sclerosis. J Neuroimmunol. 2014; 271(1-2):56-9.</li>
                <li>Moreno M, Sáenz-Cuesta M, Castilló J, Cantó E, Negrotto L, Vidal-Jordana A, Montalban X, 
                Comabella M. Circulating levels of soluble apoptosis-related molecules in patients with 
                multiple sclerosis. J Neuroimmunol. 2013; 263(1-2):152-4.</li>
                <li>Cantó E, Reverter F, Morcillo-Suárez C, Matesanz F, Fernández O, Izquierdo G, Vandenbroeck 
                K, Rodríguez-Antigüedad A, Urcelay E, Arroyo R, Otaegui D, Olascoaga J, Saiz A, Navarro A, 
                Sanchez A, Domínguez C, Caminero A, Horga A, Tintoré M, Montalban X, Comabella M. 
                Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Mult Scler. 2012; 18(7)983-90.</li>
                <li>Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, 
                Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X. Cerebrospinal fluid chitinase 
                3-like 1 levels are associated with conversion to multiple sclerosis. Brain. 2010; 133 (Pt 4):1082-93.</li>
              </ul>
            </div>
          </li>          
        </ul>                                    
      </div>
    </div>

    <br>

    <div class="callout large no-border small-padding">
      <div class="row column text-center ">
        <h1>Past Fellows</h1>
        <hr class='shorter-width black-border'>
      </div>
    </div>    

    <div class='row'>
      <div class='small-6 medium-5 medium-offset-1 columns text-center'>
        <ul class='circle-list-style left-align'>
          <li>Takuya Matsushita, M.D., Ph.D.</li>
          <li>Dorothee Nickles, Ph.D.</li>
          <li>Pierre-Antoine Gourraud, Ph.D.</li>
          <li>Britt Johnson, Ph.D.</li>
          <li>Joseph McElroy, Ph.D.</li>
          <li>Ulf Schulze Topphoff, Ph.D.</li>
          <li>Derek Pappas, Ph.D.</li>
          <li>Simona Casazza, Ph.D.</li>
          <li>Hsuan Pu Chen, Ph.D.</li>
          <li>Jean-Christophe Corvol, M.D., Ph.D.</li>
        </ul>
      </div>
      <div class='small-6 medium-5 medium-offset-1 columns text-center'>
        <ul class='circle-list-style left-align'>
          <li>Esther Byun, M.D.</li>
          <li>Enrico Pedemonte, Ph.D.</li>
          <li>Uma Sriram, Ph.D.</li>
          <li>David Brassat, M.D., Ph.D.</li>
          <li>Lisa Barcellos, Ph.D.</li>
          <li>Sergio E. Baranzini, Ph.D.</li>
          <li>Anna M. Schito, Ph.D.</li>
          <li>Yi Li, Ph.D.</li>
          <li>Antonio Uccelli, M.D.</li>
        </ul>
      </div>      
    </div>    
             

 <br>

 </div>
 </div>

    <footer class="footer">
      <div class="row full-width">
        <div class="small-3 columns left-align">
          <ul class="footer-links">
            <li><a href="mailto:msdb@ucsf.edu" class='item'>Contact Us</a></li>
          <ul>
        </div>
        <div class="small-9 columns left-align">
          <ul class="footer-links">
            <li><a class='item' href="http://msgenetics.ucsf.edu/">Multiple Sclerosis Genetics project</a></li>
            <li><a class='item' href="http://neurology.ucsf.edu/">UCSF Department of Neurology</a></li>
            <li><a class='item' href="http://multiplesclerosis.ucsf.edu/">UCSF Multiple Sclerosis Clinical Center</a></li>
            <li><a class='item' href="http://www.nmss.org">National Multiple Sclerosis Society</a></li>
            <li><a class='item' href="http://neurology.ucsf.edu/research/ms-bioscreen">MS Bioscreen</a></li>
          <ul>
        </div>
      </div>
    </footer>

    <script src="foundation/js/vendor/jquery.js"></script>
    <script src="foundation/js/vendor/what-input.js"></script>
    <script src="foundation/js/vendor/foundation.js"></script>
    <script src="foundation/js/app.js"></script>
  </body>
</html>


